e-z cinnamic acid has been researched along with Diabetes Mellitus, Adult-Onset in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barre, DE; Mizier-Barre, KA | 1 |
| Kong, LY; Luo, JG; Nie, W; Sun, HB; Wang, XB; Yao, HQ; Yin, H | 1 |
| Lee, C; Lo, YM; Moon, B; Yoo, KM | 1 |
| Cheng, J; Dey, D; Gowri, M; Gross, C; Lakner, FJ; Medicherla, S; Nag, B; Neogi, P; Pickford, LB; Sharma, SD | 1 |
| Arlt, W; Gross, C; Miller, WL; Neogi, P | 1 |
| Agejas, J; Alt, CA; Ardecky, R; Briere, DA; Brooks, DA; Brozinick, JT; Dolores Martín-Ortega, M; Ferritto, R; Fraser, JD; González, R; Hawkins, E; Lamas, C; López de Uralde, B; Martín, JA; Misener, EA; Montrose-Rafizadeh, C; Parra, F; Prieto, L; Reifel-Miller, A; Rhodes, GA; Rizzo, JR; Robey, RL; Rojo, I; Torrado, A; Warshawsky, AM; Wendel, SR; Zhang, TY | 1 |
1 review(s) available for e-z cinnamic acid and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus.
Topics: Acrolein; Animals; Caffeic Acids; Chlorogenic Acid; Cinnamates; Coumaric Acids; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hyperglycemia; Hypertension; Inflammation; Obesity, Abdominal; Polypharmacy | 2020 |
5 other study(ies) available for e-z cinnamic acid and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Synthesis of new α-glucosidase inhibitors based on oleanolic acid incorporating cinnamic amides.
Topics: alpha-Glucosidases; Amides; Cinnamates; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Ligands; Oleanolic Acid; Structure-Activity Relationship | 2011 |
The hypoglycemic effects of American red ginseng (Panax quinquefolius L.) on a diabetic mouse model.
Topics: Animals; Blood Glucose; Cinnamates; Coumaric Acids; Diabetes Mellitus, Type 2; Disease Models, Animal; Glutathione Peroxidase; Glycogen; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Malondialdehyde; Mice; Mice, Inbred Strains; Panax; Phytotherapy; Plant Extracts; Plant Roots; Superoxide Dismutase | 2012 |
Synthesis and structure-activity relationship studies of cinnamic acid-based novel thiazolidinedione antihyperglycemic agents.
Topics: Animals; Blood Glucose; Cinnamates; Diabetes Mellitus, Type 2; Disease Models, Animal; Hypoglycemic Agents; Isomerism; Mice; Phenylpropionates; Prodrugs; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Thiazolidinediones; Transcription Factors | 2003 |
Cinnamic acid based thiazolidinediones inhibit human P450c17 and 3beta-hydroxysteroid dehydrogenase and improve insulin sensitivity independent of PPARgamma agonist activity.
Topics: 17-Hydroxysteroid Dehydrogenases; 3T3 Cells; Animals; Cells, Cultured; Cinnamates; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glucose; Humans; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred Strains; PPAR gamma; Steroid 17-alpha-Hydroxylase; Structure-Activity Relationship; Thiazolidinediones; Transcriptional Activation | 2004 |
2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents.
Topics: Animals; Blood Glucose; Cinnamates; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Peroxisome Proliferator-Activated Receptors; Rats; Rats, Zucker; Structure-Activity Relationship; Triglycerides | 2005 |